Advisory board

You are here

Prof. Ernest Giralt

Co-Founder & Chairman

Professor Giralt is currently Professor of Organic Chemistry at the University of Barcelona and Coordinator of the Chemistry and Molecular Pharmacology Programme at the IRB Barcelona. He is an internationally renowned scientist in the field of peptide synthesis, medicinal chemistry, structure determination and NMR (Nuclear Magnetic Resonance). Besides, Prof. Giralt is an expert on the design of therapeutic ligands for interaction with protein surfaces. He is one of the founding members of the European Peptide Society, as well as editor of The Journal of Peptide Science. He is an inventor with 10 patents, and he serves on the advisory boards of a number of pharma and biotech companies.

Dr. Rolf Günther

Business Strategy Advisor

Dr. Günter was the CEO of Bicycle Therapeutics for 3 years, from 2012 to 2015. He participated in a successfully closing of $ 32 m financing round series A with top European and US investors. Bicycle Therapeutics has collaborated with AstraZeneca and has a license agreement with ThromboGenics. Bicycle Therapeutics is proprietary of a product platform and develops small molecular weight drug conjugates for oncology.

Prof. Javier Meana

Advisor on Pharmacology and Schizophrenia

Professor Meana is Professor of Pharmacology at the University of the Basque Country, leader of the Neuropsychopharmacology Research Group at the same centre, and head of a research group at the Spanish Centre for Biomedical Research in Mental Health (CIBERSAM), which focuses on translational activities. He has published more than 200 papers and he is a member of several international scientific societies and committees. In 2009, he received the Research Award of the Spanish Society of Biological Psychiatry.

 

Prof. Judith Jaeger

Clinical Advisor

Advisor on clinical efficacy study design. President and Principal Scientist at CognitionMetrics. She is internationally recognized clinical neuropsychologist and pharmaceutical executive. Previously Vice President for Clinical Trials at Cogstate, and Director Clinical Development at AstraZeneca.